Kemira to build two new coagulant plants at bayer sites in germany and tarragona
Business Investments
20 Feb 2011
Kemira will strengthen its european manufacturing network by constructing two new coagulant plants in germany and spain. the investment is eur 40 million and the plants are expected to be operational during 2012.
kemira has entered a strategic partnership with bayer materialscience through which it will purchase hydrochloric acid (= hcl) - a by-product of bayer’s polyurethane production - to produce coagulants for use in various water treatment applications, including drinking water and waste water treatment.
kemira will build the new coagulant plants next to bayer materialscience’s isocyanate production plants in dormagen, germany and tarragona, spain. the coagulant manufacturing in tarragona will be moved into the new plant in the bayer industrial park.
“kemira and bayer have a long history of working together. we are extremely pleased to enter this partnership, as it strengthens our position in western and southern europe, securing a long term, cost-efficient access to hydrochloric acid. coagulants are one of kemira’s core product lines and ensuring cost efficient supply of raw materials is one of our key strategic objectives”, says harri kerminen, president and ceo of kemira.
source: kemira, 18/2/2011
Related News and Success stories.
-
12 Dec 2024
Bayer expands its Expertise Hub in Barcelona with a new R&D area, welcoming 82 professionals
-
10 Dec 2024
Canadian company Talent.com creates 20 jobs at its Barcelona offices
-
29 Nov 2024
German biotech QIAGEN invests €13 million in a new global innovation center in Barcelona
-
27 Nov 2024
Canadian company Neuron IP to invest €10M to establish its first European R&D center in Barcelona